Sero AS is a Norwegian AS based in Billingstad, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 1963, the company has 76 employees and reported revenue of NOK 211.3m in its latest annual filing.
In its most recent annual report (2025), Sero AS reported revenue of NOK 211.3m, an increase of 14% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 42.4m, and the EBITDA margin stood at 26.8%.
At the end of 2025, equity financed 74.7% of the balance sheet, and current assets covered short-term debt 4.1 times.
Frequently asked questions
What is the Org number of Sero AS?
Sero AS is registered with Brønnøysundsregistrene under Org 912228738.
What is the revenue of Sero AS?
Sero AS reported revenue of NOK 211.3m in 2025.
How many employees does Sero AS have?
Sero AS employs 76 people as of the latest annual report.
Who is the CEO of Sero AS?
Jens Stefan Nicolai Kernstock is the CEO of Sero AS, in role since 2018.
Who is the chairman of Sero AS?
Knut Weydahl Eldjarn chairs the board of Sero AS, in role since 2019.
